Research

As the novel coronavirus outbreak continues to evolve, Rush University and Rush University Medical Center have put in place guidelines for our research community to help aid in containing the spread of the virus while avoiding compromising sponsored projects and laboratory studies.

June 2, 2020

May 18, 2020

  • In an effort to proactively plan for the safe re-entry of researchers into the clinical and laboratory settings at Rush, two sets of guidelines have been developed. The first is focused on laboratory research and was developed by the Laboratory Research Normalization Task Force, chaired by Anne-Marie Malfait, MD, PhD; and the second is focused on clinical research and was developed by the Clinical Research Normalization Task Force, chaired by Niranjan Karnik, MD, PhD.
  • We will follow a phased re-opening model as described in the attached plans. Please recognize that the State and City shelter-in-place order is in effect until May 29, 2020. For the next two weeks, prior to lifting of the stay-at-home order, we will continue to procure required items (PPE, signage, hand sanitizer and disinfectant), and prepare buildings for the safe continuation of research activities. The Laboratory Research Normalization Task Force developed scheduling tools to help implement measures that will enable social distancing and promote safety for all personnel.

March 18, 2020

  • We have prepared a list of Research FAQs to address issues relating to the conduct of clinical investigation, operations, sponsored projects and laboratory studies during this pandemic.
    This document is subject to change as new information is received and new government regulations are introduced. Please review the document and continue to check for updates on research procedures.
  • We have created a hub for all clinical and non-clinical coronavirus research at Rush, as well as links to access COVID-19 scientific literature and clinical trials around the world. Visit COVID-19 Science for the latest news.